Advertisement

International Journal of Clinical Pharmacy

, Volume 39, Issue 4, pp 935–944 | Cite as

Pharmacists’ perspectives of the current status of pediatric asthma management in the U.S. community pharmacy setting

  • Amanda Elaro
  • Sinthia Bosnic-Anticevich
  • Kathleen Kraus
  • Karen B. Farris
  • Smita Shah
  • Carol Armour
  • Minal R. Patel
Research Article

Abstract

Objective To explore community pharmacists’ continuing education, counseling and communication practices, attitudes and barriers in relation to pediatric asthma management. Setting Community pharmacies in Michigan, United States. Methods Between July and September 2015 a convenience sample of community pharmacists was recruited from southeastern Michigan and asked to complete a structured, self-reported questionnaire. The questionnaire elucidated information on 4 general domains relating to pharmacists’ pediatric asthma management including: (1) guidelines and continuing education (CE); (2) counseling and medicines; (3) communication and self-management practices; (4) attitudes and barriers to practice. Regression analyses were conducted to determine predictors towards pharmacists’ confidence/frequency of use of communication/counseling strategies. Main outcome measure Confidence in counseling skills around asthma. Results 105 pharmacists completed the study questionnaire. Fifty-four percent of pharmacists reported participating in asthma related CE in the past year. Over 70% of pharmacists reported confidence in general communication skills, while a lower portion reported confidence in engaging in higher order self-management activities that involved tailoring the regimen (58%), decision-making (50%) and setting short-term (47%) and long-term goals (47%) with the patient and caregiver for managing asthma at home. Pharmacists who reported greater use of recommended communication/self-management strategies were more likely to report confidence in implementing these communication/self-management strategies when counseling caregivers and children with asthma [Beta (B) Estimate 0.58 SE (0.08), p < 0.001]. Female pharmacists [B Estimate −2.23 SE (1.01), p < 0.05] and those who reported beliefs around doctors being the sole provider of asthma education [B Estimate −1.00 SE (0.32), p < 0.01] were less likely to report confidence in implementing communication/self-management strategies. Conclusion A pharmacists’ confidence may influence their ability to implement recommended self-management counseling strategies. This study showed that community pharmacists are confident in general communication. However pharmacists are reporting lower confidence levels in counseling on higher order self-management strategies with patients. More appropriate and targeted continuing education programs for pharmacists around asthma self-management education are recommended.

Keywords

Communication Community pharmacy Counseling practices Pediatric asthma Primary care United States 

Notes

Acknowledgements

We are grateful to all of the community pharmacists who participated in this study.

Funding

This work was supported by the Askwith Fund for Asthma and Allergy Research, obtained through the Centre for Managing Chronic Diseases, University of Michigan, USA.

Conflicts of interest

None.

References

  1. 1.
    Prevention CfDCa. Summary health statistics for U.S. children: National Health Interview Survey 2012. http://www.cdc.gov/nchs/data/series/sr_10/sr10_258.pdf.
  2. 2.
    National Heart LaBI. Expert panel report 3: guidelines for the diagnosis and management of asthma. Bethesda: National Institutes of Health, Department of Health and Human Services; 2015. [May 07 2017]. https://www.nhlbi.nih.gov/files/docs/guidelines/asthgdln.pdf.
  3. 3.
    Prevention CfDCa. Trends in asthma prevalence, health care use, and mortality in the United States, 2001–2010 2012. [May 06 2017]. http://www.cdc.gov/nchs/data/databriefs/db94.pdf.
  4. 4.
    Santos LA, Oliveira MA, Faresin SM, Santoro IL, Fernandes AL. Direct costs of asthma in Brazil: a comparison between controlled and uncontrolled asthmatic patients. Braz J Med Biol Res. (Revista brasileira de pesquisas medicas e biologicas/Sociedade Brasileira de Biofisica [et al.]) 2007;40(7):943-8.Google Scholar
  5. 5.
    Masoli M, Fabian D, Holt S, Beasley R. Global initiative for asthma (GINA): Global burden of asthma 2015 [May 07 2017]. http://www.ginasthma.org/.
  6. 6.
    Arnrich B, Mayora O, Bardram J, Troster G. Pervasive healthcare: paving the way for a pervasive, user-centered and preventive healthcare model. Methods Inf Med. 2010;49(1):67–73.PubMedGoogle Scholar
  7. 7.
    Cabana MD, Chaffin DC, Jarlsberg LG, Thyne SM, Clark NM. Selective provision of asthma self-management tools to families. Pediatrics. 2008;121(4):e900–5.CrossRefPubMedGoogle Scholar
  8. 8.
    Shipman SA, Sinsky CA. Expanding primary care capacity by reducing waste and improving the efficiency of care. Health Affairs (Project Hope). 2013;32(11):1990–7.CrossRefGoogle Scholar
  9. 9.
    Arend J, Tsang-Quinn J, Levine C, Thomas D. The patient-centered medical home: history, components, and review of the evidence. Mt Sinai J. Med. 2012;79(4):433–50.CrossRefPubMedGoogle Scholar
  10. 10.
    Armour C, Bosnic-Anticevich S, Brillant M, Burton D, Emmerton L, Krass I, et al. Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the community. Thorax. 2007;62(6):496–502.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Armour CL, Reddel HK, LeMay KS, Saini B, Smith LD, Bosnic-Anticevich SZ, et al. Feasibility and effectiveness of an evidence-based asthma service in Australian community pharmacies: a pragmatic cluster randomized trial. J Asthma. 2013;50(3):302–9.CrossRefPubMedGoogle Scholar
  12. 12.
    Basheti IA, Reddel HK, Armour CL, Bosnic-Anticevich SZ. Improved asthma outcomes with a simple inhaler technique intervention by community pharmacists. J Allergy Clin Immunol. 2007;119(6):1537–8.CrossRefPubMedGoogle Scholar
  13. 13.
    Benavides S, Rodriguez JC, Maniscalco-Feichtl M. Pharmacist involvement in improving asthma outcomes in various healthcare settings: 1997 to present. Ann Pharmacother. 2009;43(1):85–97.CrossRefPubMedGoogle Scholar
  14. 14.
    Bosnic-Anticevich SZ, Sinha H, So S, Reddel HK. Metered-dose inhaler technique: the effect of two educational interventions delivered in community pharmacy over time. J Asthma. 2010;47(3):251–6.CrossRefPubMedGoogle Scholar
  15. 15.
    Mehuys E, Van Bortel L, De Bolle L, Van Tongelen I, Annemans L, Remon JP, et al. Effectiveness of pharmacist intervention for asthma control improvement. Eur Respir J. 2008;31(4):790–9.CrossRefPubMedGoogle Scholar
  16. 16.
    Saini B, Krass I, Armour C. Development, implementation, and evaluation of a community pharmacy-based asthma care model. Ann Pharmacother. 2004;38(11):1954–60.CrossRefPubMedGoogle Scholar
  17. 17.
    Um IS, Armour C, Krass I, Gill T, Chaar BB. Consumer perspectives about weight management services in a community pharmacy setting in NSW, Australia. Health Expect. 2014;17(4):579–92.CrossRefPubMedGoogle Scholar
  18. 18.
    Elaro A, Shah S, Pomare LN, Armour CL, Bosnic-Anticevich SZ. PACE: Pharmacists use the power of communication in paediatric asthma. Int J Clin Pharm. 2014;36(5):976–85.CrossRefPubMedGoogle Scholar
  19. 19.
    Lemay KS, Saini B, Bosnic-Anticevich S, Smith L, Stewart K, Emmerton L, et al. An exploration of clinical interventions provided by pharmacists within a complex asthma service. Pharm Pract. 2015;13(1):529.CrossRefGoogle Scholar
  20. 20.
    Bunting BA, Cranor CW. The Asheville Project: long-term clinical, humanistic, and economic outcomes of a community-based medication therapy management program for asthma. J Am Pharm Assoc (2003). 2006;46(2):133–47.CrossRefGoogle Scholar
  21. 21.
    Elaro A, Shah S, Armour CL, Bosnic-Anticevich SZ. A snapshot of pharmacist attitudes and behaviours surrounding the management of paediatric asthma. J Asthma. 2015.Google Scholar
  22. 22.
    Kritikos VS, Reddel HK, Bosnic-Anticevich SZ. Pharmacists’ perceptions of their role in asthma management and barriers to the provision of asthma services. Int J Pharm Pract. 2010;18(4):209–16.PubMedGoogle Scholar
  23. 23.
    Clark NM, Valerio MA. The role of behavioural theories in educational interventions for paediatric asthma. Paediatr Respir Rev. 2003;4(4):325–33.CrossRefPubMedGoogle Scholar
  24. 24.
    Cabana MD, Slish KK, Evans D, Mellins RB, Brown RW, Lin X, et al. Impact of physician asthma care education on patient outcomes. Pediatrics. 2006;117(6):2149–57.CrossRefPubMedGoogle Scholar
  25. 25.
    Clark NM, Cabana MD, Nan B, Gong ZM, Slish KK, Birk NA, et al. The clinician-patient partnership paradigm: outcomes associated with physician communication behavior. Clin Pediatr. 2008;47(1):49–57.CrossRefGoogle Scholar
  26. 26.
    Shah S, Sawyer SM, Toelle BG, Mellis CM, Peat JK, Lagleva M, et al. Improving paediatric asthma outcomes in primary health care: a randomised controlled trial. Med J Aust. 2011;195(7):405–9.CrossRefPubMedGoogle Scholar
  27. 27.
    Margolis KL, Asche SE, Bergdall AR, Dehmer SP, Groen SE, Kadrmas HM, et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA. 2013;310(1):46–56.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Weber CA, Ernst ME, Sezate GS, Zheng S, Carter BL. Pharmacist-physician comanagement of hypertension and reduction in 24-hour ambulatory blood pressures. Arch Intern Med. 2010;170(18):1634–9.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Santschi V, Chiolero A, Paradis G, Colosimo AL, Burnand B. Pharmacist interventions to improve cardiovascular disease risk factors in diabetes: a systematic review and meta-analysis of randomized controlled trials. Diabetes Care. 2012;35(12):2706–17.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Gerber BS, Rapacki L, Castillo A, Tilton J, Touchette DR, Mihailescu D, et al. Design of a trial to evaluate the impact of clinical pharmacists and community health promoters working with African-Americans and Latinos with diabetes. BMC Public Health. 2012;12:891.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Pape GA, Hunt JS, Butler KL, Siemienczuk J, LeBlanc BH, Gillanders W, et al. Team-based care approach to cholesterol management in diabetes mellitus: two-year cluster randomized controlled trial. Arch Intern Med. 2011;171(16):1480–6.CrossRefPubMedGoogle Scholar
  32. 32.
    Grover C, Goel N, Chugh K, Gaur SN, Armour C, van Asperen PP, et al. Medication use in Indian children with asthma: the user’s perspective. Respirology (Carlton, Vic). 2013;18(5):807-13.Google Scholar
  33. 33.
    Grover C, Armour C, Asperen PPV, Moles R, Saini B. Medication use in children with asthma: not a child size problem. J Asthma. 2011;48(10):1085–103.CrossRefPubMedGoogle Scholar
  34. 34.
    Capanoglu M, Dibek Misirlioglu E, Toyran M, Civelek E, Kocabas CN. Evaluation of inhaler technique, adherence to therapy and their effect on disease control among children with asthma using metered dose or dry powder inhalers. J Asthma. 2015;52(8):838–45.CrossRefPubMedGoogle Scholar
  35. 35.
    Roydhouse JA, Shah S, Toelle BG, Sawyer SM, Mellis CM, Usherwood TP, et al. A snapshot of general practitioner attitudes, levels of confidence and self-reported paediatric asthma management practice. Aust J Prim Health. 2011;17(3):288–93.CrossRefPubMedGoogle Scholar
  36. 36.
    Farland MZ, Byrd DC, McFarland MS, Thomas J, Franks AS, George CM, et al. Pharmacist-physician collaboration for diabetes care: the diabetes initiative program. Ann Pharmacother. 2013;47(6):781–9.CrossRefPubMedGoogle Scholar
  37. 37.
    Furbish SML, Kroehl ME, Loeb DF, Lam HM, Lewis CL, Nelson J, et al. A pharmacist–physician collaboration to optimize benzodiazepine use for anxiety and sleep symptom control in primary care. J Pharm Pract. 2016.Google Scholar
  38. 38.
    Hirsch JD, Steers N, Adler DS, Kuo GM, Morello CM, Lang M, et al. Primary care–based, pharmacist–physician collaborative medication-therapy management of hypertension: a randomized, pragmatic trial. Clinical Therapeutics. 2014;36(9):1244–54.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Abdelnour M, Armour CL, Reddel HK, Bosnic-Anticevich SZ. Multidisciplinary asthma care teams: the role of the specialist pharmacist [online]. Aust Pharm. 2011;30(8):686–91.Google Scholar
  40. 40.
    Bradley CL, Luder HR, Beck AF, Bowen R, Heaton PC, Kahn RS, et al. Pediatric asthma medication therapy management through community pharmacy and primary care collaboration. J Am Pharm Assoc. 2016;56(4):455–60.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing 2017

Authors and Affiliations

  • Amanda Elaro
    • 1
  • Sinthia Bosnic-Anticevich
    • 1
    • 2
  • Kathleen Kraus
    • 3
  • Karen B. Farris
    • 4
  • Smita Shah
    • 5
  • Carol Armour
    • 1
    • 2
  • Minal R. Patel
    • 3
  1. 1.The Woolcock Institute of Medical ResearchUniversity of SydneySydneyAustralia
  2. 2.Sydney Local Health DistrictSydneyAustralia
  3. 3.Department of Health Behavior and Health EducationUniversity of Michigan School of Public HealthAnn ArborUSA
  4. 4.Department of Clinical PharmacyUniversity of Michigan College of PharmacyAnn ArborUSA
  5. 5.Primary Health Care Education and Research UnitWestern Sydney Local Health DistrictSydneyAustralia

Personalised recommendations